NCT00743652View on ClinicalTrials.gov

Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.

PHASE3CompletedINTERVENTIONAL
Enrollment

373

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Pneumococcal Disease13-valent Pneumococcal Vaccine
Interventions
BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

4 doses of 13vPnC (0.5ml, IM) will be administered. (3 doses infant series, and 1 toddler dose)

BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

3 doses of 13vPnC (0.5ml, IM) will be administered. (2 doses for infant series catch-up, and 1 toddler dose)

BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

2 doses of 13vPnC (0.5ml, IM) will be administered. (1 dose infant series catch-up, and 1 toddler dose)

BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

2 doses of 13vPnC (0.5ml, IM) will be administered. (2 catch-up dose(s) greater than 60 days apart )

BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

1 dose of 13vPnC (0.5ml, IM) will be administered. (1 catch-up dose)

Trial Locations (21)

99545

Pfizer Investigational Site, Kongiganak

99552

Pfizer Investigational Site, Akiak

99559

Pfizer Investigational Site, Bethel

Pfizer Investigational Site, Napaskiak

Pfizer Investigational Site, Newtok

99561

Pfizer Investigational Site, Chefornak

99563

Pfizer Investigational Site, Chevak

99578

Pfizer Investigational Site, Eek

99581

Pfizer Investigational Site, Emmonak

99604

Pfizer Investigational Site, Hooper Bay

99607

Pfizer Investigational Site, Kalskag

99609

Pfizer Investigational Site, Kasigluk

99620

Pfizer Investigational Site, Kotlik

99621

Pfizer Investigational Site, Kwethluk

99622

Pfizer Investigational Site, Kwigillingok

99632

Pfizer Investigational Site, Mountain Village

99637

Pfizer Investigational Site, Toksook Bay

99641

Pfizer Investigational Site, Nunapitchuk

99657

Pfizer Investigational Site, Russian Mission

99662

Pfizer Investigational Site, Scammon Bay

99679

Pfizer Investigational Site, Tuluksak

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00743652 - Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children. | Biotech Hunter | Biotech Hunter